4HEJ | pdb_00004hej

Discovery of Selective and Potent Inhibitors of Gram-positive Bacterial Thymidylate Kinase (TMK): Compund 16


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.235 (Depositor), 0.225 (DCC) 
  • R-Value Work: 
    0.193 (Depositor), 0.186 (DCC) 
  • R-Value Observed: 
    0.195 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4HEJ

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery of Selective and Potent Inhibitors of Gram-Positive Bacterial Thymidylate Kinase (TMK).

Martinez-Botella, G.Breen, J.N.Duffy, J.E.Dumas, J.Geng, B.Gowers, I.K.Green, O.M.Guler, S.Hentemann, M.F.Hernandez-Juan, F.A.Joseph-McCarthy, D.Kawatkar, S.Larsen, N.A.Lazari, O.Loch, J.T.Macritchie, J.A.McKenzie, A.R.Newman, J.V.Olivier, N.B.Otterson, L.G.Owens, A.P.Read, J.Sheppard, D.W.Keating, T.A.

(2012) J Med Chem 55: 10010-10021

  • DOI: https://doi.org/10.1021/jm3011806
  • Primary Citation Related Structures: 
    4GSY, 4HDC, 4HEJ

  • PubMed Abstract: 

    Thymidylate kinase (TMK) is an essential enzyme in bacterial DNA synthesis. The deoxythymidine monophosphate (dTMP) substrate binding pocket was targeted in a rational-design, structure-supported effort, yielding a unique series of antibacterial agents showing a novel, induced-fit binding mode. Lead optimization, aided by X-ray crystallography, led to picomolar inhibitors of both Streptococcus pneumoniae and Staphylococcus aureus TMK. MICs < 1 μg/mL were achieved against methicillin-resistant S. aureus (MRSA), S. pneumoniae, and vancomycin-resistant Enterococcus (VRE). Log D adjustments yielded single diastereomers 14 (TK-666) and 46, showing a broad antibacterial spectrum against Gram-positive bacteria and excellent selectivity against the human thymidylate kinase ortholog.


  • Organizational Affiliation
    • AstraZeneca Infection Innovative Medicines, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA. gabriel@sagerx.com

Macromolecule Content 

  • Total Structure Weight: 47.37 kDa 
  • Atom Count: 3,384 
  • Modeled Residue Count: 395 
  • Deposited Residue Count: 410 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Thymidylate kinase
A, B
205Staphylococcus aureus subsp. aureus N315Mutation(s): 0 
Gene Names: SA0440tmk
EC: 2.7.4.9
UniProt
Find proteins for P65249 (Staphylococcus aureus (strain N315))
Explore P65249 
Go to UniProtKB:  P65249
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP65249
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
14D

Query on 14D



Download:Ideal Coordinates CCD File
C [auth A]5-methyl-1-[(3S)-1-{3-[3-(trifluoromethyl)phenoxy]benzyl}piperidin-3-yl]pyrimidine-2,4(1H,3H)-dione
C24 H24 F3 N3 O3
OVDFDRSJZJQKLN-IBGZPJMESA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.235 (Depositor), 0.225 (DCC) 
  • R-Value Work:  0.193 (Depositor), 0.186 (DCC) 
  • R-Value Observed: 0.195 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 45.348α = 90
b = 90.308β = 100.69
c = 50.07γ = 90
Software Package:
Software NamePurpose
JDirectordata collection
AMoREphasing
BUSTERrefinement
d*TREKdata reduction
d*TREKdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2012-10-24
    Type: Initial release
  • Version 1.1: 2013-01-02
    Changes: Database references
  • Version 1.2: 2024-02-28
    Changes: Data collection, Database references, Derived calculations, Refinement description